ACT Monitoring - Platelet Inhibitors ReoPro –elevates ACTs Study used FTCA510 and Medtronics HR-ACT –target time = 250 sec with ReoPro determined usin
{"Image DocumentName": "ACT Monitoring - Platelet Inhibitors", "Image ImageDescription": "ReoPro. elevates ACTs. Study used FTCA510 and Medtronics HR-ACT. target time = 250 sec with ReoPro. determined using FTCA510 tube. Integrelin. No reported clinically significant effects on ACT. Slight decrease in ACT. Study used FTCA510 and ACT-LR. Aggrastat. No reported effects on ACT.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}